ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Phoenix, AZ, USA:

Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

Phase 3

Candel Therapeutics

Phoenix, Arizona, United States and 72 other locations

To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

Active, not recruiting
Neuroendocrine Prostate Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Phoenix, Arizona, United States and 20 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + olaparib

Phase 2

Xencor
Xencor

Phoenix, Arizona, United States and 16 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Phoenix, Arizona, United States and 105 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Phoenix, Arizona, United States and 29 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Placebo
Drug: Apalutamide

Phase 3

Aragon Pharmaceuticals

Chandler, Arizona, United States and 388 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Gilbert, Arizona, United States and 249 other locations

prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Ipatasertib
Drug: Placebo

Phase 3

Roche
Roche

Scottsdale, Arizona, United States and 183 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy results in an imp...

Active, not recruiting
Prostatic Neoplasms
Radiation: 74-80 Grays (units of radiation)
Drug: GnRH (agonist)

Phase 3

Aragon Pharmaceuticals

Scottsdale, Arizona, United States and 271 other locations

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...

Enrolling
Prostate Cancer
Drug: Radium-223
Drug: Docetaxel 60 mg/m2

Phase 3

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Gilbert, Arizona, United States and 62 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems